期刊文献+

经方为主治疗椎基底动脉供血不足性眩晕疗效观察 被引量:4

Clinical Observation of Classical Prescription with Western Medicine on Vertigo du to Vertebrobasilar Artery Insufficiency
下载PDF
导出
摘要 目的:观察中西医结合治疗椎基底动脉供血不足性眩晕的疗效。方法:采用随机对照观察,将椎基底动脉供血不足性眩晕患者84例,分为2组,每组42例。对照组给予盐酸氟桂利嗪胶囊5mg天/口服,川芎嗪120mg天/静滴;治疗组在对照组的基础上根据中医辨证给予中药治疗。观察2周。结果:治疗组显效28例,有效11例,无效3例,总有效率92.86%;对照组显效14例,有效18例,无效10例,总有效率76.19%。两组比较具有显著性差异(P<0.05)。结论:中西医结合治疗椎基底动脉供血不足性眩晕优于单独西医治疗。 Objective : To observe the therapeutic effect of integration of Chinese and Western medicine on vertigo due to vertebrobasilar artery insufficiency. Methods: 84 cases with vertigo due to vertebrobasilar artery insufficiency were randomly divided into two groups. There were 42 patients in every group. The contrast group accepted flunarizine hydreehloride capsules 5 mg and lignstrazine 30 mg per day. The treatment group accepted traditional medicine by syndrom differentiation based on control group. The whole duration of treatment was 2 weeks. Results : In the treatment group , 28 cases were apparently effective , 11 cases effective, 3 cases not effective. The total effective rate of treatment group was 92. 8%. In the contrast group ,4 cases were apparently effective ,18 cases effective, 10 cases not effective. The total effective rate of contrast group was 76. 19%. There was a significant difference between the two groups ( P 〈 0. 05 ). Conclusion : The effect of integration of Chinese and Western medicine on vertigo due to vertebrebasilar insufficiency is superior to that of western medicine.
出处 《中华中医药学刊》 CAS 2007年第6期1259-1260,共2页 Chinese Archives of Traditional Chinese Medicine
关键词 椎基底动脉供血不足 眩晕 中西医结合 vertebrobasilar artery insufficiency vertigo integration of Chinese and Western medicine
  • 相关文献

参考文献5

二级参考文献29

  • 1粟秀初.西比灵在神经系统疾病中的应用[J].陕西医学杂志,1993,22(1):44-46. 被引量:4
  • 2廖继录,孙成秀,魏美秀,龙小慧.西比灵的临床应用[J].中国医院药学杂志,1994,14(7):296-296. 被引量:3
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33037
  • 4吴正礼 周炎林 等.氟桂嗪治疗动脉硬化症、头痛和眩晕339例[J].新药与临床,1988,7:43-44.
  • 5田牛 李向红.甲襞微循环观测.临床微循环检测手册[M].北京:中国医药科技出版社,1992.9-18.
  • 61LassenNA.ClinicalNeuropharmacology1990;13(Suppl3)∶S1-S8.
  • 72Bentue-FerrerD.DecombeR,ReymannJ-M.SchatzC.AllainH.ClinicalNeuropharmacology1990;13(Suppl3)∶S9-S25.3HeissW-DStroke1992;23∶1668-1672.
  • 84KitagawaK.MatsumotoM.MatsushitaK.etal.BrainResearch1996;716∶39-46.
  • 95KataokaK.GtafR.RosnerG.HeissW-D.Stroke1987;18∶188-194.
  • 106LassenNA.TheLancet1966;111-1115.

共引文献130

同被引文献44

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部